Safety and Efficacy of Selective, Clopidogrel-Based Strategies in Acute Coronary Syndrome: A Study-Level Meta-analysis.
Giuseppe PattiLeonardo GrisafiEnrico Guido SpinoniAndrea RognoniMarco MennuniPublished in: Thrombosis and haemostasis (2022)
As compared with prasugrel/ticagrelor treatment, alternative, selective, clopidogrel-based approaches provide a similar protection from cardiovascular events, reduce the risk of any bleeding, and are associated with a greater net benefit. These beneficial effects were prevalent with unguided de-escalation to clopidogrel.
Keyphrases
- acute coronary syndrome
- cardiovascular events
- percutaneous coronary intervention
- antiplatelet therapy
- coronary artery disease
- systematic review
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- cardiovascular disease
- atrial fibrillation
- meta analyses
- open label
- type diabetes
- combination therapy
- case control